These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9374012)

  • 1. Setting goals for drug policy: harm reduction or use reduction?
    Caulkins JP; Reuter P
    Addiction; 1997 Sep; 92(9):1143-50. PubMed ID: 9374012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications.
    Moore D; Fraser S
    Soc Sci Med; 2006 Jun; 62(12):3035-47. PubMed ID: 16413645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the harm of "harm reduction".
    Beirness DJ; Notarandrea R; Jesseman R; Perron M
    Clin Pharmacol Ther; 2008 Apr; 83(4):523-5. PubMed ID: 18349874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilemmas in harm minimization.
    Weatherburn D
    Addiction; 2009 Mar; 104(3):335-9. PubMed ID: 18855811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much can treatment reduce national drug problems?
    Reuter P; Pollack H
    Addiction; 2006 Mar; 101(3):341-7. PubMed ID: 16499507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm reduction: roads less travelled to the holy grail.
    Roche AM; Evans KR; Stanton WR
    Addiction; 1997 Sep; 92(9):1207-12. PubMed ID: 9374022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applied communitarian ethics for harm reduction: promoting a dialogue within the field.
    Fry C; Treloar C; Maher L
    Drug Alcohol Rev; 2007 Sep; 26(5):553-5. PubMed ID: 17701519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction and social policy: should addicts be paid?
    Reuter P; MacCoun RJ
    Drug Alcohol Rev; 1996 Sep; 15(3):225-30. PubMed ID: 16203376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charting WHO--goals for licit and illicit drugs for the year 2000: are we 'on track'?
    Fischer B; Kendall P; Rehm J; Room R
    Public Health; 1997 Sep; 111(5):271-5. PubMed ID: 9308373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm reduction--an ethical imperative.
    Van Beek I
    Addiction; 2009 Mar; 104(3):342-3; discussion 345-6. PubMed ID: 19207339
    [No Abstract]   [Full Text] [Related]  

  • 14. Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction'.
    Jourdan M
    Int J Drug Policy; 2009 Nov; 20(6):514-20. PubMed ID: 19349155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining the goals of national drug policy: recommendations from a working group.
    Reuter P; Caulkins JP
    Am J Public Health; 1995 Aug; 85(8 Pt 1):1059-63. PubMed ID: 7625496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
    Sobeyko J
    Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm reduction and the global drug control regime: contemporary problems and future prospects.
    Bewley-Taylor DR
    Drug Alcohol Rev; 2004 Dec; 23(4):483-9. PubMed ID: 15763753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-national comparison of risk and protective factors for adolescent substance use: the United States and Australia.
    Beyers JM; Toumbourou JW; Catalano RF; Arthur MW; Hawkins JD
    J Adolesc Health; 2004 Jul; 35(1):3-16. PubMed ID: 15193569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining harm reduction.
    Single E
    Drug Alcohol Rev; 1995; 14(3):287-90. PubMed ID: 16203323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.